Chronic Lymphocytic Leukaemia
Knowledge Centre
CLL Knowledge Centre

Treatment Optimisation in Chronic Lymphocytic Leukaemia

Click on the button below to start the activity

Start CME Activity  

Date of Activity

28 January 2016 – 28 January 2018

Target Audience

The educational content of this CME is aimed at physicians and other healthcare professionals involved in care and treatment of patients with chronic lymphocytic leukaemia (CLL)

Treatment Optimisation in Chronic Lymphocytic Leukaemia

This CME activity is made up of 5 case studies. To claim CME credit you must complete all 5 cases and achieve a score of 70% in the CME quiz.

Case Content

1

Making a diagnosis

2

First-line treatment of CLL

3

A patient with CLL and co-morbidities

4

A patient with relapsed/refractory CLL

5

A patient with high-risk CLL

 

Educational Objectives

On completion of this activity, you will be able to:

  • Describe the pathophysiology and diagnosis of CLL especially in terms of newer prognostic factors and genetic abnormalities
  • State how currently available treatments and treatment guidelines can be used to manage CLL
  • Define the causes of treatment failure or clinical relapse in patients with CLL
  • Describe the mode of action of newer therapies for CLL
  • State how newer therapies fit into treatment algorithms for CLL

Faculty Biography and Disclosures

Prof Dr Stephan Stilgenbauer, MD


Prof Dr Stephan Stilgenbauer, MD

Associate Professor / Deputy Chairman
Department of Internal Medicine
Ulm University
Germany
 

View Biography and Disclosures

Support

Janssen


This activity is supported by an unrestricted medical education grant from Janssen-Cilag, Ltd. with no content involvement.

Accreditation

EACCME UEMS‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’, made available on www.epgonline.org and organized by EPG Health Media (Europe) Ltd, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ made available on www.epgonline.org and organized by EPG Health Media (Europe) Ltd, is awarded 1 European CME credits (ECMEC's).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Additional Information

System Requirements

PC

Mac

Microsoft Windows 2000 or above.
Internet Explorer (v8 or greater), Chrome, Safari or Firefox
Adobe Acrobat Reader*

MAC OS 10.2.8
Safari or Chrome
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.

*Required to view printable (PDF) version of the lesson.

Fee Information

There is no fee for this educational activity.

Start CME activity

Click on the button below to start the activity

Start CME Activity